Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
about
Delivery of oligonucleotides with lipid nanoparticlesProduction and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein.Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.GD2-targeted immunotherapy and radioimmunotherapyNeuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastomaSerum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsMacrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of diseaseImmune therapies for neuroblastoma.Anti-GD2 antibody therapy for GD2-expressing tumors.Immunocombination therapy for high-risk neuroblastoma.Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy.Common pitfalls in preclinical cancer target validation.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignanciesAnti-GD2 immunotherapy for neuroblastoma.Reassessing the Potential of Myb-targeted Anti-cancer Therapy.
P2860
Q27024646-4A45B0F5-23DE-4963-8279-AC3F17F4381CQ33751225-29ED8376-4204-47BE-B069-602507C6D620Q34389202-7F10AC9B-21BD-4A40-92A0-F315ECBA472AQ34625339-825C3A1A-5E17-474B-9784-3E67D6F17E43Q35086721-2B26BC2C-8E9A-4621-B031-CCF078F49490Q35623435-21DDC3A9-6619-48C8-8D4C-D4AB65DE2DD5Q36184329-BF525405-729A-466A-A604-63DC610AA3D9Q37278432-D335E8CD-F13E-410A-9B09-449891B52D12Q37431356-E20FD688-17D6-41A5-ACE8-3BDAA5329717Q37702283-2DEA9F32-2CD6-4539-847C-811D0DB29878Q37991024-EF65F0BA-35D0-4D90-AA8B-49AFBA30EB9BQ38128317-B3434661-AED3-4291-9DE0-04BBEAFCCFAFQ38177364-9257238C-9290-42B8-ADEA-1995D374CBDCQ38775271-D39A5D8D-60A0-4EAE-B862-7BC9B84FE4A3Q38916529-9C540DCD-2889-4FA5-B13C-B6B442E8FC1DQ39095788-F283D1A6-E333-4CD5-BBFD-86EF835B58E9Q39837845-6371C3E3-0EEB-4742-91E2-D3B8250FC754Q42737898-0118EB96-F35A-4BB0-B8B3-BDFF3FE0C334Q47554435-D6742E0F-24BC-4CBC-B5BB-4BE7C4516676Q52576037-B013150F-2152-4969-A883-FF27F137ABDE
P2860
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immune cell-mediated antitumor ...... eotides containing CpG motifs.
@en
type
label
Immune cell-mediated antitumor ...... eotides containing CpG motifs.
@en
prefLabel
Immune cell-mediated antitumor ...... eotides containing CpG motifs.
@en
P2093
P50
P356
P1476
Immune cell-mediated antitumor ...... leotides containing CpG motifs
@en
P2093
Chiara Brignole
Mirco Ponzoni
Theresa M Allen
Vito Pistoia
P304
P356
10.1093/JNCI/DJH221
P407
P577
2004-08-01T00:00:00Z